Tectonic Therapeutic, Inc. Research And Development Expense

Quick Answer

Tectonic Therapeutic, Inc. reported Research And Development Expense of $63.49 million for the year ending 2025.

  • Tectonic Therapeutic, Inc. showed an increase of +53.5% in Research And Development Expense from 2024 to 2025.
  • This data is from Tectonic Therapeutic, Inc.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
  • XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 9 years of available data (2017 to 2025), Tectonic Therapeutic, Inc.'s Research And Development Expense has grown by 317.9%.
  • Historical annual values: Fiscal year 2025: $63.49 million | Fiscal year 2024: $41.36 million | Fiscal year 2023: $36.97 million | Fiscal year 2022: $72.19 million | Fiscal year 2021: $83.11 million | Fiscal year 2020: $87.24 million | Fiscal year 2019: $54.97 million | Fiscal year 2018: $35.10 million | Fiscal year 2017: $15.19 million.
  • Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: